SISU No. 7
Natural health product licensed in Canada
- Other names
- SISU 7, SISU 7 Joint Complex
- Licence holder
- Nestle Canada Inc. dba (Atrium Innovations/Genestra Brands/Pure Encapsulations/Garden of Life Canada/Trophic Canada/SISU/Wobenzym/Bountiful Canada Vitamins/Nature's Bounty/Vital Proteins Canada)
- NPN or DIN-HM
- 80071531
- Status
- Active licence
- Licence date
- 29 July 2016
- Revision date
- 24 July 2024
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Salix alba L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux personnes souffrant d'allergie aux dérivés salicylés.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Salix alba Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 5:1 Dry plant equivalent : 175 milligramme | 35 milligramme | Not calculated |
| Gallus gallus Source : Cartilage Potency : 14.3 % Unhydrolyzed collagen type II | 27.2 milligramme | Not calculated |
| Boswellia serrata Source : Gum oleoresin Potency : 20 % 3-Acetyl-11-keto-beta-boswellic acid | 100 milligramme | Not calculated |
| Capsicum annuum Source : Fruit | 22 milligramme | Not calculated |
| Zingiber officinale Source : Rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 140 milligramme | 35 milligramme | Not calculated |
| Curcuma longa Source : Rhizome Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 200 milligramme | 50 milligramme | Not calculated |
| Vitamine C Source : Ascorbate de calcium | 100 milligramme | 100,000 µg |
Non-medicinal ingredients
Hypromellose, Stéarate de magnésium, Cellulose microcristalline, Dioxyde de silicium, Maltodextrine, Chlorure de potassium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps to relieve joint pain & stiffness associated with osteoarthritis of the knee in as little as 7 days. Helps support joint function. Helps in the development & maintenance of bones.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product if you are allergic to acetylsalicylic acid (ASA) or other salicylates, or if you are pregnant or breastfeeding.
- Effets indésirables connus
Hypersensitivity has been known to occur; in which case, discontinue use. Some people may experience mild gastrointestinal disturbances such as diarrhea, abdominal pain, heartburn, nausea and vomiting; in which case, discontinue use.
- Précautions et mises en garde
[Relieve joint pain associated with osteoarthritis of the knee]: If symptoms persist or worsen, consult a health care practitioner. Keep out of reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. Consult a health care practitioner prior to use if you have gallstones, a bile duct obstruction, stomach ulcers, stomach inflammation or excess stomach acid. Consult a health care practitioner prior to use if you have asthma, peptic ulcer disease, or if you are taking anticoagulants or products containing acetylsalicylic acid (ASA) or other salicylates. Consult a health care practitioner if you have a liver disorder or develop symptoms of liver trouble.
Source
Official Health Canada record, licence 80071531
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2024. Photograph the packaging to check whether it has changed. Photograph the packaging